In Wednesday’s trading session, the shares of one of India’s leading integrated diagnostic chain surged 5.8 percent to Rs. 862.35 on BSE, after Kotak Mahindra Mutual Fund bought 11 lakh equity shares, equivalent to a 1.75 percent stake in the company via a bulk deal.
With a market capitalisation of Rs. 8,311.4 crore, the shares of Vijaya Diagnostic Centre Limited have delivered positive returns of nearly 72.7 percent over the past one year, and so far in 2024, it has also shown gains of around 20.2 percent.
What’s the news:
According to the 9th July bulk deal data available with the BSE, Kotak Mahindra Mutual Fund purchased a total of 18 lakh equity shares of Vijaya Diagnostic Centre, representing a 1.8 percent stake, valued at nearly Rs. 141 crore, at an average price of Rs. 783.
Also read
However, foreign investor Al Mehwar Commercial Investments LLC, a UAE-based investment advisor, offloaded 22.5 lakh equity shares in the company, or equivalent to a 2.2 percent stake, amounting to Rs. 176.2 crores.
As of March 2024, Kotak Small Cap Fund held nearly 15.32 lakh equity shares, or a 1.5 percent stake, in the company, while Al Mehwar Commercial Investments held nearly 3 percent stake in Vijaya Diagnostic.
Financials:
Vijaya Diagnostic Centre witnessed a 28.3 percent year-on-year increase in revenue from operations, climbing from Rs. 121 crore in Q4 FY22-23 to Rs. 155.2 crore in Q4 FY23-24. Similarly, the after-tax profit grew by 21.6 percent from Rs. 27.7 crore to Rs. 33.7 crore, during the same period.
On a year-on-year basis, the Earnings Before Interest, Taxes, Depreciation, and Amortisation, or EBITDA increased from Rs. 491 crore in Q4 FY22-23 to Rs. 631 crore in Q4 FY23-24, representing a growth of 28.5 percent.
Shareholding Pattern:
As of March 2024, the shareholding pattern of Vijaya Diagnostic Centre shows that the Promoters hold a majority stake of 54.06 percent, while the Foreign Institutional Investors (FII) hold a 20.09 percent stake in the company. The Retail Investors and Domestic Institutional Investors (DII) hold a 5.05 percent and 20.8 percent stake, respectively.
About the Company:
Vijaya Diagnostic Centre Limited, one of India’s largest integrated diagnostic chains, is engaged in the business of providing a wide range of diagnostic services, spanning pathological investigations, basic and high-end radiology, nuclear medicine and related healthcare services.
Written by Shivani Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
